Peter Ellmark
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 34
- Immunotherapy and Immune Responses 24
- T-cell and B-cell Immunology 6
- Immune Cell Function and Interaction 6
- Oncology 30
- CAR-T cell therapy research 23
- Cancer Immunotherapy and Biomarkers 21
- Co-authors
- Carl Borrebaeck (15 shared papers)Sara M. Mangsbo (8 shared papers)Thomas H. Tötterman (8 shared papers)Christer Wingren (6 shared papers)Anders Carlsson (3 shared papers)Johan Ingvarsson (4 shared papers)Per Norlén (9 shared papers)Christina Furebring (11 shared papers)
- Journals
- Cancer Research (7 papers)Journal of Clinical Oncology (4 papers)Cancer Immunology Immunotherapy (4 papers)PROTEOMICS (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)
- Partner nations
- SwedenUnited StatesBelgium
In The Last Decade
Peter Ellmark
59 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 69
- Immunology 568
- Oncology 558
- Radiology, Nuclear Medicine and Imaging 346
- Molecular Biology 482
- Biomedical Engineering 220
Countries citing papers authored by Peter Ellmark
This map shows the geographic impact of Peter Ellmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ellmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ellmark more than expected).
Fields of papers citing papers by Peter Ellmark
This network shows the impact of papers produced by Peter Ellmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ellmark. The network helps show where Peter Ellmark may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Ellmark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 127 | |
| 2 | 2008 | 102 | |
| 3 | 2008 | 100 | |
| 4 | 2006 | 95 | |
| 5 | 2019 | 95 | |
| 6 | 2014 | 87 | |
| 7 | 2013 | 81 | |
| 8 | 2019 | 80 | |
| 9 | 2014 | 68 | |
| 10 | 2016 | 60 | |
| 11 | 2006 | 53 | |
| 12 | 2016 | 36 | |
| 13 | 2020 | 33 | |
| 14 | 2024 | 29 | |
| 15 | 2021 | 27 | |
| 16 | 2017 | 27 | |
| 17 | 2012 | 23 | |
| 18 | 2003 | 20 | |
| 19 | 2002 | 17 | |
| 20 | 2015 | 16 |
About Peter Ellmark
Peter Ellmark is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Surgery, having authored 62 papers that have together received 1.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (29 papers), Immunotherapy and Immune Responses (24 papers), CAR-T cell therapy research (23 papers), Cancer Immunotherapy and Biomarkers (21 papers), Advanced Biosensing Techniques and Applications (11 papers), Glycosylation and Glycoproteins Research (10 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Immunology (568 citations), Oncology (558 citations), Radiology, Nuclear Medicine and Imaging (346 citations), Molecular Biology (482 citations) and Biomedical Engineering (220 citations). Peter Ellmark has collaborated with scholars based in Sweden, United States and Belgium. Frequent co-authors include Carl Borrebaeck, Sara M. Mangsbo, Thomas H. Tötterman, Christer Wingren, Anders Carlsson, Johan Ingvarsson, Per Norlén, Christina Furebring, Linda C. Sandin and Niina Veitonmäki. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Cancer Immunology Immunotherapy, PROTEOMICS and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.